Categories: Research

QBI Coronavirus Research Group races toward a cure

The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

Hunting for a cure for COVID-19: an insider’s story

The chief operating officer of the Quantitative Biosciences Institute (QBI) shares a view of the team's work on COVID-19.

2020 Mary Anne Koda-Kimble Seed Award for Innovation fuels vital research across the School

The award funds the boldest, riskiest, and most blue-sky ideas.

Sample medications and detailing visits add to costs, Guglielmo argues

Free samples of medications and “detailing visits” are costly, B. Joseph Guglielmo argues in JAMA.

FDA, academia, and industry join forces to shepherd new therapies to patients

UCSF-Stanford CERSI brings together scientists, industry, and government regulators to get new therapies to patients sooner.

VR drug discovery makes precision therapy a reality

ChimeraX, virtual reality software developed at the UCSF Resource for Biocomputing, Visualization and Informatics, is now the tool of choice for computational structural biologists in the School of Pharmacy. The Jacobson Lab recently used ChimeraX to find a promising new cure for a drug-resistant...

Pathogenic Landscape of HIV

School scientists identify faulty molecular recycling as potential driver of Alzheimer’s disease

School scientists recently uncovered how neurons normally recycle old proteins, and how this process goes awry in Alzheimer's disease, leading to the toxic building of protein fragments in the brain.

2019 Koda-Kimble Seed Award supports School of Pharmacy’s boldest ideas

The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.

Pages